Investor · 1 deal

CEPI

Disclosed deals

Every published round CEPI took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.

Company	Stage	Announced	Amount	Role	Alongside	Sources
Vaxxas	Grant	19 Jan 2023	≤$6.4m	Participant	Australian Government Coalition for Epidemic Preparedness Innovations	@AuManufacturing (Fri 20 Jan 2023), Brandon BioCatalyst portfolio, Brandon Capital portfolio, @AuManufacturing (Thu 19 Jan 2023)

Portfolio

Companies CEPI has backed in a published round, and companies whose existing shares it bought off another holder.

Company	What it does	First invested	Rounds	Led
Vaxxas		19 Jan 2023, Grant	1	0

Funds

Fund closes reported for CEPI, as distinct from the investments it has made.

Fund	Announced	Committed	Target	Close	Sources
No fund closes recorded for CEPI yet.

Portfolio companies acquired

Companies CEPI has backed that another company then bought. An exit for the holding, not a deal CEPI did.

Company	Bought by	Kind	Announced	Price
No portfolio company of CEPI is recorded as having been acquired.

People

Name	Role	Sources
Jane Halton	Chair	Brandon BioCatalyst portfolio, Brandon Capital portfolio
Richard Hatchett	CEO	Brandon BioCatalyst portfolio, Brandon Capital portfolio

Something wrong? Tell us

CEPI

Disclosed deals

Portfolio

Funds

Portfolio companies acquired

People

Coverage

Vaxxas Announces Interim Phase I Study Results for First Needle-Free HD-MAP COVID-19 Vaccine

Vaxxas Appoints Dr. Rochelle Chaiken as Chief Medical Officer

Coming in from the cold: needle-free patch technology for mRNA vaccines aims to end need for frozen storage and improve access